Skip to main content
OpenTrials

Clinical trial condition

Relapsed/Refractory Primary Central Nervous System Lymphoma

Explore clinical trials studying Relapsed/Refractory Primary Central Nervous System Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Relapsed/Refractory Primary Central Nervous System Lymphoma trial results

Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

NCT07104032

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • HonorHealth Cancer Center Scottsdale, Arizona, United States
  • Providence Medical Foundation Fullerton, California, United States
  • UC Irvine Health Orange, California, United States
View all 20 locations
View Trial Details

Related conditions